ctrl K

Price Alert

REGENXBIO Inc. (RGNX)

NASDAQ: RGNX · Real-Time Price · USD

8.82

-0.24 (-2.65%)

At close: Aug 15, 2025, 3:59 PM

8.88

0.62%

After-hours: Aug 15, 2025, 05:44 PM EDT

REGENXBIO Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	57.53M	34.52M	96.95M	345.21M
Short-Term Investments	177.16M	240.74M	267.69M	112.23M
Long-Term Investments	10.18M	38.87M	200.56M	391.91M
Other Long-Term Assets	6.5M	7.54M	9.93M	10.72M
Receivables	20.47M	26.34M	28.08M	32.44M
Inventory	n/a	n/a	13.9M	18.75M
Other Current Assets	12.68M	18.85M	9.35M	10.2M
Total Current Assets	278M	334.97M	415.98M	518.83M
Property-Plant & Equipment	171.31M	192.59M	206.8M	192.45M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	187.99M	239M	417.29M	595.08M
Total Assets	465.99M	573.97M	833.27M	1.11B
Account Payables	22.8M	22.79M	27.21M	11.39M
Deferred Revenue	115K	148K	1.83M	3.33M
Short-Term Debt	7.9M	n/a	6M	1.75M
Other Current Liabilities	20.46M	86.04M	71.33M	92.4M
Total Current Liabilities	103.19M	130.27M	130.43M	130.47M
Long-Term Debt	25.38M	n/a	n/a	n/a
Other Long-Term Liabilities	29.01M	49.73M	97.84M	134.21M
Total Long-Term Liabilities	103.14M	131.96M	186.64M	219.13M
Total Liabilities	206.34M	262.23M	317.07M	349.61M
Total Debt	82.03M	89.29M	94.8M	86.68M
Common Stock	5K	4K	4K	4K
Retained Earnings	-932.15M	-705.05M	-441.55M	-161.23M
Comprehensive Income	-741K	-4.43M	-15.4M	-2.57M
Shareholders Equity	259.65M	311.74M	516.2M	764.3M
Total Investments	187.34M	279.61M	468.25M	504.14M